The research in the Sabatino Laboratory is focused on hemophilia, an inherited bleeding disorder. The interests of the laboratory include the study of variants of coagulation factor VIII to understand the biochemical properties of these proteins and to identify novel variants with enhanced function, and the development of gene-based therapeutic approaches for treating hemophilia.

Dr. Saby uses electrophysiological techniques to characterize aspects of brain function and development in children with neurodevelopmental disabilities.

Dr. Sainath is an attending physician in the Division of Gastroenterology, Hepatology, and Nutrition at CHOP and an assistant professor of Pediatrics at the Perelman School of Medicine in the University of Pennsylvania. Her research focuses on pediatric gastroenterology and nutrition.

Amy Salovin, assistant director, Office of Faculty Development, builds strong programs and resources that promote academic success. She is committed to supporting the career progression of research investigators at all levels.

Dr. Samelson-Jones is a pediatric hematologist dedicated to improving the lives of children with bleeding and clotting disorders. His research focuses on gene therapy for hemophilia, the biochemical basis of coagulation, and the immune responses to hemophilia therapies.

Dr. Sankar is a pediatric orthopaedic surgeon and director of the Young Adult Hip Preservation Program at CHOP and professor of Orthopaedic Surgery at the University of Penn. His research forcuses on hip conditions in children, adolescents, and young adults, as well as scoliosis and other spinal disorders.

Dr. Jill Savla is an attending cardiologist at Children's Hospital of Philadelphia. Her research interests include congenital heart disease, early life risk factors for congenital heart surgery, maternal-fetal environment, outcomes research, and clinical epidemiology.

Dr. Schoeman is a research assistant whose focus is Interventional Radiology.

Dr. Schofield's research focuses on neurocognitive outcomes of oncology treatment. Her areas of interest are acute and long-term neurotoxicities and cognitive sequelae of cellular therapy, including hematopoietic stem cell transplant and chimeric antigen receptor (CAR) T-cell therapy.

Dr. Schreiber is a pediatric neuropsychologist in the Department of Child and Adolescent Psychiatry and Behavioral Sciences and the Division of Pediatric General, Thoracic and Fetal Surgery at CHOP. Her research focuses on neurobehavioral outcomes in children with complex medical conditions.

Julie Schrey is a Research Technician in the Kurre Laboratory working to elucidate the role of extracellular vesicles secreted from hematopoietic stem and progenitor cells in the inflammatory leukemic niche.

Dr. Schultz's research involves using magnetic resonance imaging to understand brain mechanisms and to create biomarkers that predict who has autism spectrum disorder (ASD), who will develop the disorder, and who will respond well to different interventions. More recently, he has developed a technology and innovation lab to exploit advances in perceptual computing, in order to develop more robust measurements of quantitative traits.

Dr. Schwartz's research focuses on behavioral and psychosocial aspects of cancer and its treatment in adolescents and young adults (AYAs), a group of patients with unique medical and psychosocial challenges. Most of her current studies aim to understand and improve self-management among AYAs.

Relies on extensive experience in leadership positions in institution, independent, and governmental Institutional Review Boards to support investigators while they navigate multicenter research studies.

Dr. Scribano's areas of interest and research involve the epidemiology and prevention of child maltreatment and intimate partner violence, technology use in healthcare, and health services to children in foster care.

Thomas Seacrist's research is focused on how the anatomical and developmental differences between children and adults affect their motion during motor vehicle crashes, improving child crash test dummies, and detecting driving behavior differences between novice teen and experienced adult drivers.

Christa Seidman, MSPH, is a clinical research program manager for multiple areas in gastrointestinal research.

Dr. Seif's research centers on manipulating the human innate and immune systems to treat children with acute lymphoblastic leukemia (ALL). The long-term goal of her research is to identify innate and adaptive immune mechanisms that can be used to treat pediatric ALL more effectively, and with less toxicity, than existing therapies.

Dr. Sengupta is a neonatologist and physician scientist with a long-standing interest in lung health. She studies the mechanisms of circadian regulation of lung inflammation, injury, and repair; and the effect of early life exposures on development and function of pulmonary circadian networks in adulthood.

Dr. Serai is an MRI physicist who has developed and applied MR imaging-based methods for iron quantification, fat quantification, elastography for liver fibrosis, and T1/T2 mapping techniques to suit pediatric needs.

Dr. Sgourakis’ research focuses on understanding the intricate molecular mechanisms that determine the vast repertoire of peptide antigens displayed by the proteins of the Major Histocompatibility Complex for immune surveillance by T cells and Natural Killer cells.

Dr. Shah's research is centered on understanding obesity and its related complications. Her current work includes clinical and translational studies exploring pathophysiology and modulation of obesity-related adipose tissue and systemic inflammation using human cell lines and clinical trials. She is also involved in clinical studies of outcomes and risk factors of polycystic ovarian syndrome and type 2 diabetes in teens.

Dr. Shah's clinical research interests are focused in the areas of neurofibromatosis type 1 and retinoblastoma. These studies range from translational studies to clinical trials of novel therapeutics to international consortiums studying long-term effects of therapy.

Dr. Shalem’s research focuses on translational target discovery for a range of neurodegenerative diseases. He combines technology development of large-scale CRISPR-based perturbation screens with application of such technology together with additional genomic approaches.

Dr. Shankar is the medical director and associate chief in the Division of Cardiac Critical Care Medicine at CHOP and a professor of Clinical Anesthesiology and Critical Care at the University of Pennsylvania. His research focuses on pediatric cardiac critical care and cardio-pulmonary interactions.

Matt Shapiro is a former high school science teacher who recently transitioned to a career in laboratory research. He is a research technician in the Wolpaw Lab where his research is focused on how lineage state impacts the transcriptional regulation of cGAS-STING signaling in neuroblastoma.

Dr. Shaw is an emergency medicine physician, clinical epidemiologist, and national leader in the fields of pediatric emergency medicine and quality and patient safety. She is most noted for her research in the diagnosis and management of acute pediatric illness and injuries, most notably UTI,
dehydration, and bronchiolitis.

Dr. Shih studies the metabolic interplay between cell types within the neurovascular unit during stroke to develop effective, novel mitochondrial-directed therapeutics to improve post-stroke disability. She works with small and large animal models of childhood arterial ischemic stroke.

Dr. Shu's research focuses on developing and applying suitable statistical methods for assessing comparative safety and effectiveness of medical products.

Dr. Shukla focuses on the study of clinical and patient reported outcomes in robot-assisted laparoscopy and the bladder exstrophy-epispadias complex. He also investigates hypospadias, urinary reflux, hydronephrosis, and complex urinary tract reconstruction.

Dr. Shults works to develop statistical methods for longitudinal data that include semi-parametric approaches to account for subject/cluster level associations and maximum likelihood-based approaches for simulation and analysis of discrete longitudinal outcomes that may have overdispersion.

Dr. Silber is the director of the Center for Outcomes Research at CHOP, and is an internationally known authority on outcomes measurement and severity adjustment for both adult and pediatric applications.

Dr. Silverman studies the fundamental aspects of early-life commensal microbes that influence immune system development and function. He discovered that the MHC-II E molecule prevents type 1 diabetes by shaping the intestinal microbiota early in life.

Elizabeth Silvestro is the Additive Manufacturing Engineering Manager for the Children’s Hospital Additive Manufacturing for Pediatrics 3D Labs.

The principal goal of Dr. Simmons' research program is to elucidate the underlying molecular mechanisms that link an aberrant intrauterine milieu to the later development of diseases in adulthood. She has made many seminal contributions to the understanding of the role that epigenetic modifications play in developmental programming of obesity and type 2 diabetes.

Dr. Simpao, a pediatric anesthesiologist and clinical informatician, has a strong track record of innovation and research. He's led projects that use visual analytics and machine learning models to derive insights and predict outcomes using large healthcare data sets.

Dan Singleton delivers actionable clinical data to researchers and provides tools for efficient data management and reconciling data capture in the clinical domain with secondary use for research purposes.

Dr. Smith is a laboratory animal medicine veterinarian. As Technical Director of the CCMT Comparative Medicine Services Core, he helps guide promising therapeutics and devices from discovery and developmental studies through nonclinical studies.